This webinar aims to inform and answer participants questions on the HEAL Pain Therapeutics Development Program (PTDP) and the funding announcement RFA-NS-24-019. The purpose of this notice of funding opportunity (NOFO) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising early therapeutic molecules and to facilitate readiness for the Early Phase Pain Investigation Clinical Network (EPPIC-Net) or other Phase II clinical studies.
FULL EVENT INFO HEAL Pain Therapeutics Development Program (PTDP) Webinar: Focus on “Non-Addictive Analgesic Therapeutics Development (Small Molecules and Biologics) to Treat Pain”
December 1, 2023 pm Eastern Time (US and Canada)
Moderated by HEAL (PTDP) Program Director Dr. Mary Ann Pelleymounter
After registering, you will receive a confirmation email containing information about joining the webinar.